Utilization of PTNS During Office-Based Cystoscopy
Utilization of PTNS During Office-Based Cystoscopy
This study will be a double-blind, randomized control trial, with one additional unblinded
 arm. This study has been designed to identify a means of improving quality of life for
 patients requiring in-office cystoscopy. Percutaneous tibial nerve stimulation (PTNS) has
 been shown to improve quality of life and symptom control in multiple urological conditions
 based on shared neuroanatomical structures between the genitourinary system and the tibial
 nerve The goal of this project is to demonstrate the efficacy and safety of PTNS in
 minimizing patient discomfort during cystoscopy to develop a larger randomized control trial
 in the near future.
Inclusion Criteria:

 -  Patients 18 years of age or older

 -  Patients undergoing routine office-based cystoscopy by a urology provider

 Exclusion Criteria:

 -  Patients for whom ancillary procedures are performed during cystoscopy, including
 ureteral stent removal, bladder stone removal, biopsy, or fulguration

 -  Patients undergoing cystoscopy due to concern for urologic injury

 -  Patients undergoing cystoscopy due to concern for prosthetic abnormality, including
 erosion or malposition

 -  Patients who perform clean intermittent catheterization

 -  Patients with pre-existing neurological pathology, including but not limited to
 multiple sclerosis, spinal cord injury, Parkinson's disease, or peripheral neuropathy
 of any etiology

 -  Patients having undergone prior non-endoscopic prostatectomy (radical prostatectomy,
 simple prostatectomy)

 -  Patients with a history of interstitial cystitis/chronic pelvic pain

 -  Patients who have taken an analgesic (excluding 81mg aspirin) in the past 12 hours

 -  Patients with a history of urethral stricture disease